Scientists are exploring a new way to fight infections using bacteriophages. These are viruses that target and kill specific bacteria. A recent narrative review examined how these phages interact with our immune system, specifically macrophages. Macrophages are white blood cells that eat germs and help control inflammation. The study looked at several things, including how phages clear themselves from the body and how they change the way macrophages function. It also checked how these viruses affect the release of chemicals that cause or stop inflammation. The review found that phages can change how macrophages polarize and what functions they perform. This interaction is important for understanding how these treatments might work in the future. However, this is a review of existing ideas, not a new clinical trial with patient data. The information helps researchers understand the basic science behind using phages to treat disease.
Bacteriophages modulate macrophage functions and immune responses in therapeutic applicationsReview explores how bacteriophages interact with immune cells
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This narrative review synthesizes current knowledge on the interactions between bacteriophages and macrophages, focusing on their role in therapeutic phage applications. The authors discuss how phages are cleared by macrophages and how they modulate immune responses, including macrophage polarization, secretion of pro- and anti-inflammatory cytokines, and modulation of phagocytic functions. These interactions are critical for understanding the efficacy and safety of phage therapy. The review highlights that while preclinical studies show promise, clinical evidence is sparse and many mechanisms remain incompletely understood. The authors do not report specific study populations, sample sizes, or comparators, and no pooled effect sizes are provided. Limitations include the lack of standardized methods across studies and the absence of human clinical trial data on these specific interactions. For clinicians, the review underscores the potential of phage therapy but emphasizes that its clinical translation requires further rigorous investigation.